The Certified Methadone Advocate Course

Saturday, October 16, 2004 Preconference Events

Frederick W. Christie, MA

AFIRM

Long Island, New York
H. Westley Clark, MD, JD, MPH

CSAT

Rockville, MD
Stewart Leavitt, PHD

Addiction Treatment Forum

Glenview, IL
James P. Connolly, CMA

PA NAMA

Newtown, PA
Herman Joseph, PHD, CMA

NAMA

New York, NY
J. Thomas Payte, MD, CMA

Colonial Management Group

Orlando, FL
Walter Ginter, CMA

NAMA

Westport, CT
Thomas Kresina

NIDA/CSAT

Rockville, MD
Joycelyn Woods, MA, CMA

NAMA

New York, NY

It is the view of the National Alliance of Methafdone Advocates (NAMA) that everyone who supports the use of methadone treatment is a potential methadone advocate. We encourage all supporters of methadone treatment, patients and non-patient, to become Certified Methadone Advocates (CMAs) so that all the energies directed toward the advancement of methadone tratment produce positive results.

This course fulfills the training requirement for Certification as a Methadone Advocate. It is designed for non-clinicians and involves 8 hours of rigorius training. The course equips participants with the tools they will nedd to succeed in the strugle to have methadone maintenance treatment universally acceptied as the “gold standard” for addiction treatment.

With these goals in mind the course presetation is as follows:

  • Addiction and Methadone – scientifically accurate yet in language understandable to the non-clinician.
  • Regulation and Accreditation – explained by experts from the Center for Substance Abuse Treatment (CSAT) who understand the systemic complexities.
  • Methadone Mythology – exposing the myths surrounding methadone treatment.
  • The Certified Methadone Advocate (CMA) – the mechanism of certification and how it will professionalize those committed to advocacy, includes advocacy on the Net and Methadone Anonymous.
  • Methadone Stigma – a history of administrative and community prejudice directed at methadone patients, plus analyses of possible solutions.
  • Office-Based Treatment Model – whether buprenorphrine or methadone, an advance for patients and an administrative hurdle for implementation.
  • Hepatitis C – the second most important subject for all methadone patients.

Sponsored by the National Alliance of Methadone Advocates.

Supported by the National Institute on Drug Abuse, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment and Mallinckrodt, Inc.

Similar Posts

  • Links & Resources

    Admin 04/10/2021

    We Speak Methadone Join NAMA’s Bulletin Board and talk with other patients or just read what is happening around the world. SAMHSA Substance Abuse and Mental Health Services Administration. The federal agency that oversees mental health, substance abuse treatment and prevention agencies. CSAT Center for Substance Abuse Treatment. The federal agency under SAMHSA that oversees…

  • Stigma: The Invisible Barrier by Herman Joseph and Joycelyn Woods

    Admin 12/13/2021

    Herman Joseph, Ph.D. is a member of NAMA’s Advisory Board and has been involved in methadone treatment and research since it’s beginning. This article is excerpted from Herman Joseph’s dissertation on stigma. Methadone maintenance treatment has been subjected to professional trivialization and misunderstandings, has consistently received sensationalized negative media coverage and been the target of…

  • Publication Index

    Admin 02/09/2022

    Journal Articles Anderson, J. Methadone, history, pharmacology, outcomes, clinical issues and future trends. Advance 2002 April: 42-48. (PDF Format) Coates, E.A.; Brennan, D.; Logan, R.M.; Goss, A.N.; Scopacasa, B.; Spencer, A.J.; Gorkic, E. Hepatitis c and associated health problems. Australian Dental Journal 2000 45(2): 108-114. (PDF Format) D’Aunno, T.; Pollack, H.A. Changes in Methadone Treatment…

  • September is Recovery Month

    Admin 11/12/2022

    Get Ready for National Recovery Month in September NAMA declares 2003 THE YEAR OF RECOVERY FOR METHADONE PATIENTS Methadone patients have never been allowed to think of themselves as in recovery. This year the National Alliance of Methadone is declaring Recovery Month “The Year of Recovery for Methadone Patients.” What can you do to make…

  • NAMA Policy Statement: On the Practice of Diluting Methadone

    Admin 08/09/2022

    The dilution of methadone with water was initiated as a result of the first federal methadone regulations because it was believed that this policy would reduce the diversion of methadone. While initially this policy may have had an impact within a short time most prospective buyers learning that methadone was now diluted with water knew…

  • NAMA Website Map

    Admin 03/27/2022

    About NAMA Dear Advocate Letter What is NAMA Methadone 101 Course Introduction History of Methadone Methadone Treatment Discovery of Endorphins Methadone as Normal Medicine Methadone Awareness Test Membership Information Membership Application The News NAMA News Upcoming Conferences NAMA e-Alert WebZine NAMA Library Library Catalog NAMA Publications Index NAMA Policy Statements Index NAMA Education Series Index…